Selected article for: "asymptomatic infection and respiratory tract infection"

Author: Simon P. Jochems; Fernando Marcon; Beatriz F. Carniel; Mark Holloway; Elena Mitsi; Emma Smith; Jenna F. Gritzfeld; Carla Solórzano; Jesús Reiné; Sherin Pojar; Elissavet Nikolaou; Esther L. German; Angie Hyder-Wright; Helen Hill; Caz Hales; Wouter A.A de Steenhuijsen Piters; Debby Bogaert; Hugh Adler; Seher Zaidi; Victoria Connor; Jamie Rylance; Helder I. Nakaya; Daniela M. Ferreira
Title: Inflammation induced by influenza virus impairs innate control of human pneumococcal carriage
  • Document date: 2018_6_20
  • ID: 4fgz09cv_7
    Snippet: To test whether this was specific for LAIV infection, we measured IP-10 in nasal washes from an 102 independent cohort in which a subset of subjects had asymptomatic viral upper respiratory tract 103 infection before Spn inoculation. These comprised rhinovirus (n=12), coronavirus (n=5), respiratory 104 syncytial virus (n=2) and parainfluenzavirus (n=1) 29 . The predominant virus, rhinovirus, was 105 recently shown to associate with increased pneu.....
    Document: To test whether this was specific for LAIV infection, we measured IP-10 in nasal washes from an 102 independent cohort in which a subset of subjects had asymptomatic viral upper respiratory tract 103 infection before Spn inoculation. These comprised rhinovirus (n=12), coronavirus (n=5), respiratory 104 syncytial virus (n=2) and parainfluenzavirus (n=1) 29 . The predominant virus, rhinovirus, was 105 recently shown to associate with increased pneumococcal acquisition and transmission 30 . In these 106 virus-infected subjects, levels of IP-10 were increased (Fig S2) , and baseline IP-10 levels 107 correlated with increased pneumococcal density also in this second cohort (r = 0.32, p = 0.02, Fig 108 1e ). While the correlation was modest in this validation cohort suggesting that other host and 109 environmental factors are involved, this is the first time a biomarker predicting Spn density has 110 been identified.

    Search related documents:
    Co phrase search for related documents
    • independent cohort and LAIV infection: 1
    • independent cohort and second cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • independent cohort and Spn density: 1
    • independent cohort and spn inoculation: 1
    • independent cohort and subject subset: 1
    • independent cohort and syncytial virus: 1, 2, 3, 4
    • independent cohort and validation cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • LAIV infection and pneumococcal acquisition: 1
    • LAIV infection and pneumococcal density: 1
    • LAIV infection and second cohort: 1
    • LAIV infection and Spn density: 1
    • LAIV infection and spn inoculation: 1
    • nasal wash and pneumococcal density: 1, 2, 3, 4
    • nasal wash and second cohort: 1
    • nasal wash and Spn density: 1
    • nasal wash and syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • nasal wash and validation cohort: 1